We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The GMP Letter: Subscribe Now!
Email
Tweet

The GMP Letter: Subscribe Now!

Subscribe Now

The GMP Letter

You’ve probably wished you had access to the inner workings of the FDA. A trusted friend in the organization with deep insight into FDA’s interpretation and enforcement of cGMPs and quality systems regulation. You’d turn to this person often for valuable information to help you stay in compliance and maintain — or increase — your competitive edge.

The GMP Letter is your go-to resource. GMP has the insights and information you can rely on to ensure your processes, procedures and controls are compliant.

Each month, The GMP Letter’s executive briefings bring you the latest on:

  • FDA’s approach to facility inspections such as the agency’s increasing focus on data security
  • Changes to the EU’s inspections for MDR compliance
  • Joint recognition of GMP inspections in the U.S., EU and other jurisdictions
  • Quality regulations and guidances for instance on cybersecurity and data integrity
  • And much more…

For the past 30 years, devicemakers who have relied on The GMP Letter have had much-needed information and analysis, enabling them to act swiftly to adjust manufacturing processes.

Bonus! You’ll also receive critical documents including 483s, warning letters, closeout letters, FDA policy notices and more.

Start your one-year subscription (12 issues) to The GMP Letter for only $1,085. You’ll immediately gain access to the latest issue as well as a searchable database of 30 years of past issues.

We’re confident the value GMP provides you will pay for itself many times over. If you disagree, there’s our 100% Money-Back Guarantee.

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • AstraZeneca

    AstraZeneca Withdraws Imfinzi’s Bladder Cancer Indication

  • CE mark

    Cue Health’s COVID-19 Test Receives CE Mark

  • Sanofi-Regeneron_Logos.png

    Sanofi’s and Regeneron’s Libtayo Wins FDA Approval for NSCLC

  • PerkinElmer logo

    PerkinElmer’s Rapid Point-of-Care COVID-19 Test Cleared in Europe

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing